Peter Lloyd

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients

Bin Peng, Michael Hayes, Debra Resta et al. · Journal of Clinical Oncology · 2004 · 470 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Formation Imaging With Microelectrical Scanning Arrays

M. P. Ekstrom, Claude A. Dahan, Minyi Chen et al. · 1986 · 223 citations

Engineering, Electrical Engineering, Manufacturing Engineering +11

Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man

Gérard Flesch, Philipp Müller, Peter Lloyd · European Journal of Clinical Pharmacology · 1997 · 201 citations

Medicine, Pharmacokinetics, Pharmacology +11

MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial

Debashis Sarker, Ruth Plummer, Tim Meyer et al. · Clinical Cancer Research · 2020 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

Absolute Bioavailability of Imatinib (Glivec®) Orally versus Intravenous Infusion

Bin Peng, Catherine Dutreix, Günther H. Mehring et al. · The Journal of Clinical Pharmacology · 2004 · 167 citations

Pharmacy, Pharmacokinetics, Pharmacology +17